Orthofix International | OFIX - Assets


Orthofix International reported $886.6M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Accuray USD 448.01M 8.81M Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 883.16M 1.64M Mar/2026
AtriCure USD 643.99M 10.19M Mar/2026
Dexcom USD 6.63B 293.4M Mar/2026
EDAP TMS EUR 61.46M 6.88M Sep/2025
Globus Medical USD 5.44B 136.79M Mar/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 2.99B 203.2M Mar/2026
Integra LifeSciences USD 3.58B 24.28M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 886.6M 35.95M Mar/2026
Plus Therapeutics USD 19.92M 3.59M Mar/2026
Smith & Nephew USD 10.69B 150M Dec/2025
STAAR Surgical USD 451.12M 560K Mar/2026
Stryker USD 46.29B 1.55B Mar/2026
Surmodics USD 169.82M 8.74M Jun/2025
Tandem Diabetes Care USD 1.15B 272.28M Mar/2026
Teleflex USD 6.78B 164.24M Mar/2026
Veracyte USD 1.44B 30.38M Mar/2026
Zimmer Biomet Holdings USD 22.72B 370.1M Mar/2026